glp-1/gip dual agonist lilly The FDA approved a new GLP-1 pill for weight loss from Eli on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' @DrLaPook has more on the new medication A list of recently developed
Description
MK-6024 P001 Study Group
You still want to have a slow, steady weight loss with slow dose titration
Preliminary data point toward beneficial effects of GIP agonism, as reported in findings from the SURPASS program that tirzepatide reduced UACR and slowed down eGFR declined in comparison with both placebo (53) and comparator drugs including insulin glargine (74, 75)
Routine clinical use of liraglutide 3 mg for the treatment of obesity: outcomes in non-surgical and bariatric surgery patients
The 5-HT3 receptor is essential for exercise-induced hippocampal neurogenesis and antidepressant effects
